Denali Therapeutics dips after pricing $200M equity offering
Source: SeekingAlpha
2025-12-10 05:34:17 ET
More on Denali Therapeutics
- Denali Therapeutics Inc. (DNLI) Analyst/Investor Day Transcript
- Denali Therapeutics Inc. (DNLI) Analyst/Investor Day - Slideshow
- Denali: Regulatory Delay Is A Strategic Opportunity
- Denali Therapeutics prices stock offering at $17.50 per share
- Denali Therapeutics announces $200M proposed offering of common stock and pre-funded warrants
Read the full article on Seeking Alpha
For further details see:
Denali Therapeutics dips after pricing $200M equity offering
Denali Therapeutics Inc.
NASDAQ: DNLI
DNLI Trading
-1.2% G/L:
$21.39 Last:
437,116 Volume:
$21.465 Open:
DNLI Latest News
February 26, 2026 04:01:00 pm
Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
February 19, 2026 08:30:00 am
Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development
DNLI Stock Data
$3,127,833,066
136,297,507
0.26%
87
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
